BioHarvest Sciences Inc. (BHST) stock
Close on Nov 12, 2026Market cap $36.95MP/E –Yield –
BioHarvest Sciences Inc. grew revenue 37.0% to $34.51M over fiscal 2025. Free cash flow was -$9.58M. At the latest close the market valued the company at $36.95M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- $36.95M
- P/E ratio
- –
- Price to sales
- 1.07
- Price to book
- 1.45
- Dividend yield
- –
- Free cash flow yield
- -25.93%
Fundamentals
- Revenue
- $34.51M
- Net income
- -$11.14M
- Free cash flow
- -$9.58M
Trading
- Previous close
- $1.75
- Open
- $1.75
- Day's range
- $1.45 – $1.85
- Volume
- 119,840
- Average volume (20 days)
- 30,791
- Beta (5 years)
- 0.88
- 52-week range
- $1.37 – $8.30
- RSI (14 days)
- 48.2
- Volatility (1 year)
- 64.2%
- Relative volume
- 2.73×
- WACC
- 9.3%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BHST | S&P 500 | Difference | BHST per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.6% | -2.7% | +3.3 pts | ||
| 3 months | -24.2% | -1.7% | −22.4 pts | ||
| Year to date | -68.6% | +11.9% | −80.5 pts | ||
| 1 year | -79.4% | +12.0% | −91.4 pts | ||
| 3 years | -60.5% | +78.2% | −138.7 pts | -26.6% | +21.2% |
| 5 years | -84.5% | +73.2% | −157.7 pts | -31.1% | +11.6% |
Four years at a glance
Fiscal years 2022 to 2025, USD
Revenue
Gross profit
Operating income
Net income
Free cash flow
Press releases
Releases BioHarvest Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About BioHarvest Sciences
Pharmaceutical Preparations
BioHarvest Sciences Inc. develops and commercializes botanical compositions, operating primarily through its specialized product sales and contract development and manufacturing organization (CDMO) services. The company focuses on the development, biomanufacturing, and distribution of plant-derived offerings and proprietary ingredient solutions, while providing contract research and development capabilities to commercial clients. Its operations serve consumer health, pharmaceutical, nutraceutical, and life sciences markets seeking standardized active plant ingredients.
Company profile, executives and historyBioHarvest Sciences stock: common questions
What is BioHarvest Sciences's stock price?
BHST closed at $1.63 on Nov 12, 2026, down 6.86% on the day. Over the past 52 weeks it traded between $1.37 and $8.30.
What is BioHarvest Sciences's market cap?
BioHarvest Sciences was worth $36.95M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
How much revenue does BioHarvest Sciences make?
BioHarvest Sciences reported revenue of $34.51M for fiscal 2025, up 37.0% from a year earlier.
Does BioHarvest Sciences pay a dividend?
No. BioHarvest Sciences has not paid a cash dividend over the last twelve months.
How has BHST stock performed over the past year?
Including dividends, BHST returned -79.4% over the past year, against +12.0% for the S&P 500.
How many BHST shares are sold short?
0M shares were sold short at the latest FINRA report, 0.33% of the float, or 5.1 days of average trading volume.
Who are BioHarvest Sciences's competitors?
Companies most similar to BioHarvest Sciences by business, industry and size include JAGX, SBFM, LXRX, INBP, BGM.
See a number that looks wrong?